Ivonescimab is an investigational therapy that is not approved by any regulatory authority in Summit's license territories, including the United States and Europe. Ivonescimab was initially approved ...

Ivonescimab was invented by Akeso Inc. (HKEX Code: 9926.HK) and is currently utilized in multiple Phase III clinical trials. Over 5,000 patients have been treated with ivonescimab in clinical studies ...

PD-1 bispecific antibodies combine checkpoint blockade with CTLA-4 or VEGF targeting. Can one engineered molecule offer ...

From 3D-printed models to filming on a 130-foot research vessel, discover how the 'Below' crew brought Josh Hartnett's ...

When SARS-CoV-2 first swept across the globe in early 2020, the pharmaceutical world faced a brutal mismatch: conventional ...

"Are drugs with stronger effects on muscles also more harmful to the body?" Information surrounding trenbolone is a mixture ...

Turning uneditable files into workable layers, but there's a catch ...

The upcoming stage musical adaptation of La La Land has hired two of the people who helped fashion the look and movement of ...

AI is accelerating antibiotic discovery, but clinical translation requires standardized data, safety optimization, and new ...

ArtCraft isn't ready to replace Adobe's Photoshop and Premiere yet.

Canva has introduced ProSuite, bringing together specialist creative applications and AI-assisted workflows to help ...

Canva will bundle its offering for professional designers in the new Canva ProSuite. It combines the Affinity graphics software, the Cavalry 2D animation program, the Flourish data visualization tool, ...